Commercial

Connected Wearable Patch Shipments to Reach 35.1 Million Units Annually by 2022, According to Tractica

November 15, 2017

BOULDER, Colo.–(BUSINESS WIRE)–Connected wearable patches include patches, tattoos, or small devices that are affixed to the skin and worn for a limited time, from an hour to several weeks. The patches also have an element of wireless connectivity, and have a medical, health, or wellness purpose that can range from monitoring physiological data to delivering […]

Fasenra (Benralizumab) Receives US FDA Approval For Severe Eosinophilic Asthma

November 15, 2017

WILMINGTON, Del., November 14, 2017) – AstraZeneca (NYSE:AZN) and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved FASENRA™ (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype. FASENRA is not approved […]

Former CenterWatch COO Joan Chambers Joins SCORR Marketing as Senior Strategic Advisor

November 14, 2017

Kearney, Neb., Nov. 14, 2017 (Business Wire) — SCORR Marketing, a global health science marketing and communications firm, has announced the appointment of Joan Chambers as senior strategic advisor. In her role, Chambers will capitalize on her extensive health science industry experience to provide strategic direction to SCORR’s global clients to help them meet their […]

Grand River Aseptic Manufacturing Announces Majority Investment by Arlington Capital Partners

November 14, 2017

Grand Rapids, Mich., Nov. 14, 2017 (Business Wire) — Grand River Aseptic Manufacturing (GRAM), a leading provider of high-quality, sterile parenteral solutions, has a new majority owner: Arlington Capital Partners, a private equity firm in the Washington, D.C., area. Among other things, the new partnership will provide funding for GRAM to expand and add capacity […]

FDA Renews and Expands its Portfolio of Simcyp Simulator (PBPK) Licenses

November 14, 2017

Increased Use of Physiologically-based Pharmacokinetic (PBPK) Modeling and Simulation (M&S) is a Priority in Both the Prescription Drug User Fee Act and Generic Drug User Fee Amendments Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of Certara’s […]

US Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics

November 13, 2017

–-PGDx’s Pan-Cancer Profiling Panels with MSI Testing for Immuno-Oncology Applications Are Now Available Nationwide to Cancer Patients Treated at the VA–                                                                                                   –PGDx’s CancerSELECTTM 125 Offers Comprehensive Tissue-Based Tumor Profiling and Its PlasmaSELECTTM 64 Is First Liquid Biopsy Assay Available to Patients at VA Facilities— BALTIMORE, MD –Personal Genome Diagnostics Inc. (PGDx) today announced the renewal […]

Cmed to Demonstrate how encapsia® Transforms Clinical Trial Data Management, Capture and Reporting at Leading Oncology Meetings

November 13, 2017

HORSHAM, UK — November 13, 2017 – Cmed, an oncology focused, innovative technology-led CRO, today announced that it will showcase its encapsia® clinical data suite at two leading oncology meetings, Clinical Operations in Oncology Trials Europe, taking place 5-6 December in Munich, Germany, and the ASH Annual Meeting, taking place 9-12 December in Atlanta, GA. […]

Sciformix Corporation Collaborates with Oracle Health Sciences to Offer Full Service Validated Argus Enterprise Edition Drug Safety Solutions

November 13, 2017

Boston, MA. – November 10, 2017, – Sciformix Corporation, a leading scientific knowledge-based organization, is proud to announce its adoption of Oracle Argus Enterprise Edition platform to offer superior value to their customers in the Life Science industry. Through its collaboration with Oracle Health Sciences, Sciformix is able to offer its customers a fully automated […]

DuraTherm PLUS+ is an ISTA-validated shipping solution for temperature-sensitive payloads

November 10, 2017

Denver, CO – ACH Foam Technologies announces DuraTherm PLUS+™, an advanced cold chain shipping solution that assures payload temperatures remain between 2⁰ to 8⁰ Celsius for a 24-hour delivery window. Validated to International Safe Transit Association (ISTA) 7D standards, DuraTherm PLUS+™ is available in summer and winter profiles to accommodate off-the-shelf seasonal packout solutions for […]

FEEDBACK